These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12205453)

  • 1. Inflammation takes on Alzheimer disease.
    Golde TE
    Nat Med; 2002 Sep; 8(9):936-8. PubMed ID: 12205453
    [No Abstract]   [Full Text] [Related]  

  • 2. Killing pain, killing neurons?
    Wyss-Coray T
    Nat Med; 2005 May; 11(5):472-3. PubMed ID: 15875048
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta and Alzheimer disease therapeutics: the devil may be in the details.
    Cirrito JR; Holtzman DM
    J Clin Invest; 2003 Aug; 112(3):321-3. PubMed ID: 12897198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and Alzheimer disease: the good, the bad, and the ugly.
    Weninger SC; Yankner BA
    Nat Med; 2001 May; 7(5):527-8. PubMed ID: 11329045
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen, inflammation and Alzheimer disease.
    Wyss-Coray T; Mucke L
    Nat Med; 2000 Sep; 6(9):973-4. PubMed ID: 10973311
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inflammation, nonsteroidal anti-inflammatory drugs and Alzheimer disease].
    Lacomblez L
    Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):298-9. PubMed ID: 15706674
    [No Abstract]   [Full Text] [Related]  

  • 10. A case for a non-transgenic animal model of Alzheimer's disease.
    Stéphan A; Phillips AG
    Genes Brain Behav; 2005 Apr; 4(3):157-72. PubMed ID: 15810904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
    van Groen T; Kadish I
    Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.
    McGeer EG; McGeer PL
    Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of a treatment for Alzheimer's disease and potential immunonosuppresive therapeutic interventions.
    Dhawan N; Puangco J; Jandial R
    Neuro Endocrinol Lett; 2008 Aug; 29(4):410-20. PubMed ID: 18766151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
    Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
    Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C; Hosokawa M; McGeer PL
    Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
    Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bringing amyloid into focus.
    Golde TE; Bacskai BJ
    Nat Biotechnol; 2005 May; 23(5):552-4. PubMed ID: 15877070
    [No Abstract]   [Full Text] [Related]  

  • 20. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
    Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.